458 related articles for article (PubMed ID: 30168025)
1. Angiogenesis in pancreatic cancer: current research status and clinical implications.
Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and angiogenesis in pancreatic cancer.
Garcea G; Doucas H; Steward WP; Dennison AR; Berry DP
ANZ J Surg; 2006 Sep; 76(9):830-42. PubMed ID: 16922908
[TBL] [Abstract][Full Text] [Related]
3. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
Craven KE; Gore J; Korc M
Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and antiangiogenic strategies in pancreatic cancer.
Fisher WE; Berger DH
Int J Gastrointest Cancer; 2003; 33(1):79-88. PubMed ID: 12909740
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived proangiogenic cells in pancreatic cancer.
Mizukami Y
J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic therapy in ovarian cancer: current situation & prospects.
Liu Y; Luo Y; Cai M; Shen P; Li J; Chen H; Bao W; Zhu Y
Indian J Med Res; 2021 May; 154(5):680-690. PubMed ID: 35532586
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic carcinogenesis: apoptosis and angiogenesis.
Onizuka S; Kawakami S; Taniguchi K; Fujioka H; Miyashita K
Pancreas; 2004 Apr; 28(3):317-9. PubMed ID: 15084979
[TBL] [Abstract][Full Text] [Related]
8. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenesis therapy in pancreatic carcinoma.
Saif MW
JOP; 2006 Mar; 7(2):163-73. PubMed ID: 16525200
[TBL] [Abstract][Full Text] [Related]
10. Cytokine network: new targeted therapy for pancreatic cancer.
Matsuo Y; Takeyama H; Guha S
Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
[TBL] [Abstract][Full Text] [Related]
11. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis.
Li X; Zhou J; Wang X; Li C; Ma Z; Wan Q; Peng F
Biomed Pharmacother; 2023 Jul; 163():114806. PubMed ID: 37163782
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
13. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
14. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas.
Pluda JM; Parkinson DR
Cancer; 1996 Aug; 78(3 Suppl):680-7. PubMed ID: 8681307
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of angiogenesis in cancers.
Pang RW; Poon RT
Vasc Health Risk Manag; 2006; 2(2):97-108. PubMed ID: 17319453
[TBL] [Abstract][Full Text] [Related]
17. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
18. Twist promotes angiogenesis in pancreatic cancer by targeting miR-497/VEGFA axis.
Liu A; Huang C; Cai X; Xu J; Yang D
Oncotarget; 2016 May; 7(18):25801-14. PubMed ID: 27015364
[TBL] [Abstract][Full Text] [Related]
19. A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.
Rajkumar SV; Mesa RA; Tefferi A
J Hematother Stem Cell Res; 2002 Feb; 11(1):33-47. PubMed ID: 11847002
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.
Fujioka S; Yoshida K; Yanagisawa S; Kawakami M; Aoki T; Yamazaki Y
Cancer; 2001 Oct; 92(7):1788-97. PubMed ID: 11745251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]